SCHEMBL4538794

SCHEMBL4538794

O=C(O)CCCCCCCCCCCCCCCl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.71
LMNA P02545 3/20 0.71
NFKB1 P19838 1/20 0.71
PMP22 Q01453 1/20 0.71
GPR84 Q9NQS5 8/20 0.57
FFAR1 O14842 2/20 0.57
FFAR4 Q5NUL3 2/20 0.57
SLC22A6 Q4U2R8 2/20 0.56
PPARG P37231 7/20 0.55
PPARD Q03181 7/20 0.55
PPARA Q07869 7/20 0.55
HDAC11 Q96DB2 5/20 0.55
ALDH1A1 P00352 3/20 0.55
PTPN1 P18031 3/20 0.55
TLR2 O60603 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
MEN1 O00255 2/20 0.55
FABP4 P15090 2/20 0.55
ALOX15 P16050 2/20 0.55
KMT2A Q03164 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4528673 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4529391 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4523092 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4536782 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4528659 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4528703 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4539447 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL1264657 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4516520 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4522258 1.00 TSHR (0.71) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9440891-B2 Palladium-catalyzed decarbonylation of fatty acid anhydrides for the production of linear alpha olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-09-13 US disclosed
US-9440891-B2 Palladium-catalyzed decarbonylation of fatty acid anhydrides for the production of linear alpha olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-09-13 US disclosed
US-9440891-B2 Palladium-catalyzed decarbonylation of fatty acid anhydrides for the production of linear alpha olefins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-09-13 US disclosed
EP-2928850-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS California Institute of Technology (US) 2015-10-14 EP disclosed
WO-2014088897-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-06-12 WO disclosed
WO-2014088897-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-06-12 WO disclosed
US-20140155666-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-06-05 US disclosed
US-20140155666-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-06-05 US disclosed
US-20140155666-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-06-05 US disclosed
US-20090123516-A1 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2009-05-14 US disclosed
WO-2007019478-A2 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-02-15 WO disclosed
EP-0525479-B1 Spicamycin derivatives and the use thereof KIRIN BREWERY (JP) 1997-11-05 EP disclosed
US-5631238-A ANTICARCINOGENIC AGENTS KIRIN BEER KABUSHIKI KAISHA (JP) 1997-05-20 US disclosed
US-5461036-A Treating colon, gastric, esophageal cancer KIRIN BEER KABUSHIKI KAISHA (JP) 1995-10-24 US disclosed
EP-0525479-A1 Spicamycin derivatives and the use thereof KIRIN BEER KABUSHIKI KAISHA (JP) 1993-02-03 EP disclosed
US-3993773-A Control of mites with esters of cyclopropane substituted carboxylic acids ZOECON CORPORATION (US) 1976-11-23 US disclosed
US-3969384-A Esters of cyclopropane alkanoic acids ZOECON CORPORATION (US) 1976-07-13 US disclosed
US-3960907-A MITICIDES ZOECON CORPORATION (US) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155666-A1 PALLADIUM-CATALYZED DECARBONYLATION OF FATTY ACID ANHYDRIDES FOR THE PRODUCTION OF LINEAR ALPHA OLEFINS FASN, FFAR2, ACSL4 TSHR 3390/4885LMNA 4260/4885NFKB1 1989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.